CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 37 filers reported holding CATALYST BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $32,000 | +166.7% | 18,000 | 0.0% | 0.01% | +225.0% |
| Q1 2022 | $12,000 | -25.0% | 18,000 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $16,000 | -90.8% | 18,000 | -57.1% | 0.01% | -94.0% |
| Q3 2021 | $173,000 | -4.9% | 42,000 | 0.0% | 0.08% | +16.9% |
| Q2 2021 | $182,000 | -5.2% | 42,000 | +10.5% | 0.07% | -12.3% |
| Q1 2021 | $192,000 | – | 38,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,320,000 | $871,000 | 0.13% |
| Nantahala Capital Management | 2,420,789 | $1,598,000 | 0.07% |
| Ikarian Capital, LLC | 476,625 | $314,000 | 0.04% |
| Kynam Capital Management, LP | 106,089 | $70,000 | 0.02% |
| Essex Woodlands Management, Inc. | 78,622 | $52,000 | 0.01% |
| Gyon Technologies Capital Management, LP | 23,421 | $15,000 | 0.01% |
| JOHNSON & JOHNSON | 66,951 | $44,000 | 0.01% |
| RBF Capital, LLC | 132,396 | $87,000 | 0.01% |
| Colorado Capital Management, Inc. | 13,712 | $9,000 | 0.01% |
| Black Diamond Financial, LLC | 18,000 | $12,000 | 0.00% |